The U.S. Food and Drug Administration (FDA) has cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease. The clearing by the FDA is the first time that a test has been indicated to follow a new testing paradigm in which two tests called enzyme immunoassays (EIA)… Continue reading New Tests Cleared by the FDA Provide An Easier Diagnosis for Lyme Disease